Cargando…
Comparison of cholinesterase inhibitor safety in real-world practice
INTRODUCTION: Cholinesterase inhibitors (ChEIs) are widely used to treat mild to moderate Alzheimer's disease and related dementia. Clinical trials have focused on placebo comparisons, inadequately addressing within-class comparative safety. METHODS: New users of ChEIs in British Columbia were...
Autores principales: | Carney, Greg, Bassett, Ken, Wright, James M., Maclure, Malcolm, McGuire, Nicolette, Dormuth, Colin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944712/ https://www.ncbi.nlm.nih.gov/pubmed/31921965 http://dx.doi.org/10.1016/j.trci.2019.09.011 |
Ejemplares similares
-
Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009) -
Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010) -
Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia
por: Fisher, Anat, et al.
Publicado: (2019) -
A cluster randomized trial assessing the impact of personalized prescribing feedback on antibiotic prescribing for uncomplicated acute cystitis to family physicians
por: Carney, Greg, et al.
Publicado: (2023) -
Outcomes associated with hospital admissions for accidental opioid overdose in British Columbia: a retrospective cohort study
por: Morrow, Richard L, et al.
Publicado: (2019)